Enhancing Clinical Trial Sites in Low- and Middle-Income Countries to Facilitate Product Development in Response to the COVID-19 Pandemic.
Saved in:
| Title: | Enhancing Clinical Trial Sites in Low- and Middle-Income Countries to Facilitate Product Development in Response to the COVID-19 Pandemic. |
|---|---|
| Authors: | Kang SSY; International Vaccine Institute, Seoul, Republic of Korea.; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom., Tadesse BT; International Vaccine Institute, Seoul, Republic of Korea.; Department of Global Public Health, Karolinska Institute, Stockholm, Sweden.; Center for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.; Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany., Jeon HJ; International Vaccine Institute, Seoul, Republic of Korea.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Fallah MP; Africa Centres for Disease Control and Prevention, Science and Innovation Directorate, Addis Ababa, Ethiopia., Dereje N; Africa Centres for Disease Control and Prevention, Science and Innovation Directorate, Addis Ababa, Ethiopia., Ilesanmi OS; Africa Centres for Disease Control and Prevention, Science and Innovation Directorate, Addis Ababa, Ethiopia., Abay SM; International Vaccine Institute, Seoul, Republic of Korea.; Department of Pharmacology and Clinical Pharmacy, Addis Ababa University, Addis Ababa, Ethiopia., Tekle BI; International Vaccine Institute, Seoul, Republic of Korea., Son HG; International Vaccine Institute, Seoul, Republic of Korea., Shrestha L; Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal., Shrestha A; Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal., Ramiso HV; Tropical Disease Foundation, Makati City, Philippines., Canouet V; International Vaccine Institute, Seoul, Republic of Korea., Kim Y; International Vaccine Institute, Seoul, Republic of Korea.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom., Asante KP; Kintampo Health Research Centre, Research and Development Division, Ghana Health Service, Kintampo, Ghana., Anim J; Kintampo Health Research Centre, Research and Development Division, Ghana Health Service, Kintampo, Ghana., Kaali S; Kintampo Health Research Centre, Research and Development Division, Ghana Health Service, Kintampo, Ghana., Capeding MR; Tropical Disease Foundation, Makati City, Philippines.; Asian Hospital and Medical Center, Muntinlupa City, Metro Manila, Philippines., Jani IV; Instituto Nacional de Saùde, Maputo, Mozambique., Capitine I; Instituto Nacional de Saùde, Maputo, Mozambique., Mahumane A; Instituto Nacional de Saùde, Maputo, Mozambique., Wartel TA; International Vaccine Institute, Seoul, Republic of Korea., Haselbeck AH; International Vaccine Institute, Seoul, Republic of Korea., Saluja T; International Vaccine Institute, Seoul, Republic of Korea., Marks F; International Vaccine Institute, Seoul, Republic of Korea.; Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.; The Hong Kong Jockey Club Global Health Institute, Hong Kong Special Administrative Region, China. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2025 Jul 22; Vol. 80 (12 Suppl 2), pp. S1-S8. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-6591 |
|---|---|
| DOI: | 10.1093/cid/ciaf094 |
